The price of a breath

In a beautiful coral island of Maldives, the first sign wasn’t a crisis, but a pattern. At six months old, as Ehan began to move and crawl, his skin told a story his parents couldn’t yet read—deep bruises appearing on pressure points that shouldn’t have been there. It took three months of persistent questions and a battery of blood tests before the reality was named: Hemophilia
Suddenly, childhood became a series of boundaries. While other children ran and tumbled, Ehan’s world was restricted to avoid any strenuous activity. School, which should have been his first big adventure, was skipped entirely; the fear of a single playground fall turning into an internal crisis was simply too high a price to pay.
His life became a calendar of infusions. Muscle bleeds and gum bleeds were met with Factor. By June 2019, they started a prophylactic routine of factor treatment every three days, hoping to stay one step ahead of the “invisible” bleeds.
But the medical path is rarely a straight line. During a routine lab draw for inhibitor screening, Ehan developed a muscular bleed at the needle site. When the usual Factor infusions failed to stop the bleeding, the fear that every hemophilia parent carries became a reality. The results confirmed it: Ehan had developed inhibitors. His body was rejecting the very treatment he needed.
The family traveled to abroad for answers. A new treatment plan was drafted and executed. Ehan has found a medicine that works, but his parents are still in the trenches, fighting every day to ensure the supply line never breaks.